BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29720863)

  • 1. Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues.
    Papadopoulos N; Papavdi M; Pavlidou A; Konstantinou D; Kranidioti H; Kontos G; Koskinas J; Papatheodoridis GV; Manolakopoulos S; Deutsch M
    Ann Gastroenterol; 2018; 31(3):365-370. PubMed ID: 29720863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals.
    Calvaruso V; Ferraro D; Licata A; Bavetta MG; Petta S; Bronte F; Colomba G; Craxì A; Di Marco V
    J Viral Hepat; 2018 Jan; 25(1):72-79. PubMed ID: 28703895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
    Yeh ML; Huang CF; Huang CI; Holmes JA; Hsieh MH; Tsai YS; Liang PC; Tsai PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Chung RT; Yu ML
    J Hepatol; 2020 Jul; 73(1):62-71. PubMed ID: 32061869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
    De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
    J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy.
    Colombatto P; Palmisano E; Ricco G; Cavallone D; Oliveri F; Coco B; Salvati A; Romagnoli V; Surace L; Vatteroni M; Pistello M; Virdis A; Bonino F; Brunetto MR
    J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Hepatitis B Reactivation Among Chinese Individuals With Chronic Hepatitis C Treated With Pan-Oral Direct-Acting Antivirals.
    Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
    Gastroenterology Res; 2018 Apr; 11(2):124-129. PubMed ID: 29707079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.
    Cheng X; Uchida T; Xia Y; Umarova R; Liu CJ; Chen PJ; Gaggar A; Suri V; Mücke MM; Vermehren J; Zeuzem S; Teraoka Y; Osawa M; Aikata H; Tsuji K; Mori N; Hige S; Karino Y; Imamura M; Chayama K; Liang TJ
    J Clin Invest; 2020 Jun; 130(6):3205-3220. PubMed ID: 32163375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.
    Mücke VT; Mücke MM; Peiffer KH; Weiler N; Welzel TM; Sarrazin C; Zeuzem S; Berger A; Vermehren J
    Aliment Pharmacol Ther; 2017 Aug; 46(4):432-439. PubMed ID: 28627791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients.
    Tseng CW; Liu WC; Ko PH; Chen YC; Tseng KC; Chang TT
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.
    Chen G; Wang C; Chen J; Ji D; Wang Y; Wu V; Karlberg J; Lau G
    Hepatology; 2017 Jul; 66(1):13-26. PubMed ID: 28195337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.
    Yeh ML; Huang CF; Hsieh MH; Ko YM; Chen KY; Liu TW; Lin YH; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang CI; Huang JF; Kuo PL; Dai CY; Yu ML; Chuang WL
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1754-1762. PubMed ID: 28230928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Reactivation Following Eradication of HCV with Direct-Acting Antiviral Drugs (DAAs) in a Cohort of Patients from Different Institutions in Egypt.
    Abdelbary MS; Samir R; El-Nahaas SM; Shahin RMH; El-Sayed M; Gaber Y; Tantawi O; Zayed NA; Yosry A
    J Clin Exp Hepatol; 2022; 12(5):1276-1284. PubMed ID: 36157140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
    Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A
    Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.
    Yanny BT; Latt NL; Saab S; Han S; Choi G; Kramer J; Sahota AK
    J Clin Gastroenterol; 2018; 52(10):908-912. PubMed ID: 29334502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.
    Loggi E; Gitto S; Galli S; Minichiello M; Conti F; Grandini E; Scuteri A; Vitale G; Di Donato R; Cursaro C; Furlini G; Andreone P
    J Clin Virol; 2017 Aug; 93():66-70. PubMed ID: 28654775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES.
    Butt AA; Yan P; Aslam S; Sherman KE; Siraj D; Safdar N; Hameed B
    Int J Infect Dis; 2020 Mar; 92():184-188. PubMed ID: 31978574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease.
    Pramoolsinsap C; Sirikulchayanonta V; Busakorn W; Poovorawan Y; Hirsch P; Theamboonlers A; Lerdverasirikul P
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):741-9. PubMed ID: 10928369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
    Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC
    Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C.
    Uyanikoglu A; Akyuz F; Baran B; Simsek BP; Ermis F; Demir K; Gulluoglu M; Badur S; Kaymakoglu S
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):485-90. PubMed ID: 23665172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.